Review article · 2009 · Open access

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.

David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G. Altman

PubMed Central, 3(3), e123–30 · Published 1 January 2009

Free PDFView at the publisherCite this paper

In brief

“Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.” is a 2009 review article by David Moher and 3 co-authors, published in PubMed Central. OpenAlex counts 49,894 citations as of 15 November 2026, which puts it in the top 1% of works published in 2009 by citations. It is open access under a CC BY-NC-SA licence: the full text is free to read at PubMed Central.

Citations
49,894
Most cited in
2021 (8,269)
Field-weighted impact
33.69
References
36
Authors
4

Abstract

Systematic reviews and meta-analyses have become increasingly important in health care. Clinicians read them to keep up to date with their field,1,2 and they are often used as a starting point for developing clinical practice guidelines. Granting agencies may require a systematic review to ensure there is justification for further research,3 and some health care journals are moving in this direction.4 As with all research, the value of a systematic review depends on what was done, what was found, and the clarity of reporting. As with other publications, the reporting quality of systematic reviews varies, limiting readers' ability to assess the strengths and weaknesses of those reviews. Several early studies evaluated the quality of review reports. In 1987, Mulrow examined 50 review articles published in 4 leading medical journals in 1985 and 1986 and found that none met all 8 explicit scientific criteria, such as a quality assessment of included studies.5 In 1987, Sacks and colleagues6 evaluated the adequacy of reporting of 83 meta-analyses on 23 characteristics in 6 domains. Reporting was generally poor; between 1 and 14 characteristics were adequately reported (mean = 7.7; standard deviation = 2.7). A 1996 update of this study found little improvement.7 In 1996, to address the suboptimal reporting of meta-analyses, an international group developed a guidance called the QUOROM Statement (QUality Of Reporting Of Meta-analyses), which focused on the reporting of meta-analyses of randomized controlled trials.8 In this article, we summarize a revision of these guidelines, renamed PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses), which have been updated to address several conceptual and practical advances in the science of systematic reviews (Box 1). Box 1 Conceptual issues in the evolution from QUOROM to PRISMA

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PubMed Central, 3(3), e123–30. https://pmc.ncbi.nlm.nih.gov/articles/PMC3090117/

MLA 9

Moher, David, et al. “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.” PubMed Central, vol. 3, no. 3, 2009, pp. e123–30. https://pmc.ncbi.nlm.nih.gov/articles/PMC3090117/.

Chicago

Moher, David, Alessandro Liberati, Jennifer Tetzlaff, and Douglas G. Altman. 2009. “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.” PubMed Central 3 (3): e123–30. https://pmc.ncbi.nlm.nih.gov/articles/PMC3090117/.

Harvard

Moher, D. et al. (2009) ‘Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.’, PubMed Central, 3(3), pp. e123–30. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC3090117/.

IEEE

D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.,” PubMed Central, vol. 3, no. 3, pp. e123–30, 2009.

BibTeX

@article{moher2009preferred,
  title     = {{Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.}},
  author    = {Moher, David and Liberati, Alessandro and Tetzlaff, Jennifer and Altman, Douglas G.},
  journal   = {PubMed Central},
  year      = {2009},
  volume    = {3},
  number    = {3},
  pages     = {e123--30},
  url       = {https://pmc.ncbi.nlm.nih.gov/articles/PMC3090117/}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20174,2754275
20184,6964696
20196,0486048
20208,1678167
20218,2698269
20221,9521952
20231,4111411
2024961961
2025697697
2026466466

Its field-weighted citation impact is 33.69: it has been cited 33.69 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews

  • PRISMA statement
  • reporting guidelines
  • systematic reviews
  • meta-analysis
  • reporting quality
  • randomized controlled trials

Work with this paper

Most-cited papers in Decision Sciences

All highly cited Decision Sciences papers

Questions about this paper

How do I cite this paper in APA style?

Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PubMed Central, 3(3), e123–30. https://pmc.ncbi.nlm.nih.gov/articles/PMC3090117/

How many times has this paper been cited?

49,894 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at PubMed Central.

Who wrote this paper?

David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G. Altman.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.